IFB FAAA 2017000182.pdf

1 of 4|

Invitation For BIDS

FAAA 2017000182

Colorado Department of Public Health & Environment

I. Background By the end of 2015, an estimated 13,052 Colorado residents were living with HIV. People Who Inject Drugs (PWID) and Men Who Have Sex With Men (MSM) with PWID risk factors accounted for

16.2 percent of persons living with HIV/AIDS.

There were 1,832 newly diagnosed HIV cases reported from 2011-2015. PWID and MSM/PWID represented 8.5 percent of those cases. Males accounted for 87.6 percent of newly diagnosed HIV cases with PWID risk factors reported from 2011-2015. Caucasians made up 62.7 percent of newly diagnosed HIV cases among PWID from 2011-2015, while Hispanic PWID made up 27.2 percent of HIV cases, and African American PWID comprised 8.3 percent of HIV cases. Newly diagnosed HIV cases among PWID were most common in 20-34 year olds in the past 5 years (53.9%). PWID HIV cases diagnosed during the five-year time period of 2011-2015 have largely been concentrated in urban areas. This is consistent with other risk groups, affirming that the Colorado HIV epidemic is largely centered in urban areas. Of PWID HIV cases, urban areas reported 95.4 percent, rural areas

4.1 percent, and frontier areas 0.5 percent. There is, however, some early evidence that injection drug use is increasing in the rural areas of Colorado.

The National HIV Behavioral Surveillance System (NHBS) was developed to help state and local health departments establish and maintain a surveillance system to monitor selected behaviors and prevention services among groups at highest risk for HIV infection. Findings from NHBS are used to enhance the understanding of HIV risk and testing behaviors in these groups, and to develop and evaluate HIV prevention programs that provide services to them. The most recent cycle of the NHBS survey among PWID in the Denver metropolitan occurred soon after legislation made Syringe Access Programs available.

The findings from NHBS related to PWID in Colorado are from three cycles of data collection (2006, 2009, and 2012) and include a total of 1,465 respondents over the three cycles. Major trends in the last cycle (2012) indicate reductions in risk behaviors, but remain problematic:

64.5 percent of PWID report sharing a non-sterile syringe;

35.5 percent of PWID indicate that they have shared a needle after someone else had used it;

55 percent of PWID reported use of a cooker, water, or cotton after someone else had used it; and

31.6 percent of PWID reported using drugs that had been divided with a used needle.

II. Purpose

The purpose of this Invitation For Bids (IFB) is to obtain competitive bid proposals from qualified vendors to distribute syringes to approved Syringe Access Programs across Colorado. Vendor must meet or exceed the specifications and additional requirements listed in this solicitation. The

2 of 4| funding for Comprehensive Injector Health Programs will be awarded through a separate RFA and is not included in the scope of this IFB. The successful bidders for this IFB will be expected to ship syringes to CDPHE designated Contractors responsible for administering syringe access programs, as evidenced by the provision of sterile syringes to CDPHE designated agencies, at no cost to the agencies.

III. Definitions AIDS Acquired Immunodeficiency Syndrome CBOH Colorado Board of Health CDC Centers for Disease Control and Prevention CDPHE Colorado Department of Public Health and Environment CFDA Catalog of Federal Domestic Assistance CHAPP Colorado HIV and AIDS Prevention Program CMS Colorado Contract Monitoring System CCR Code of Colorado Regulation CPT Current Procedural Terminology CRS Colorado Revised Statutes FRMS Financial Risk Management Survey FTE Full-Time Equivalent HIV Human Immunodeficiency Virus IFB Invitation For Bids MSM Men Who Have Sex With Men PWID People Who Inject Drugs SAP Syringe Access Program SOW Scope of Work SSP Syringe Service Programs State State of Colorado STI Sexually Transmitted Infection VH Viral Hepatitis

IV. Eligibility Consistent with regulation 6 CCR 1009-10, only the following types of non-profit organizations are eligible for award under the Colorado HIV/AIDS Prevention Program, one of the primary funding sources for this IFB:

1. A non-profit organization governed by a board of directors;

2. A tax-exempt organization under section 501 (c) (3) of the federal internal revenue code

3. A county, district, or multiple jurisdiction public health agency

NOTE: For-profit organizations are not eligible to bid. Consistent with CRS 25-4-1413 (3)a.

This is a statewide project. Bidders proposing to serve a limited geographic area will not be considered for funding under this IFB.

Bids must meet all criteria outlined in this IFB. Bidders that decline to meet one or more criteria, or do not demonstrate meeting all criteria, will not be considered for funding.

V. Project Period, Budget The proposed effective date of this agreement will be through June 30, 2017. The current funding available is $200,000.00. At the sole discretion of CDPHE, this initial budget may be increased or decreased based on availability of funds. Financial obligations of CDPHE payable after the current state fiscal year are contingent upon funds for that purpose being appropriated, budgeted, and

3 of 4| otherwise made available. In the event funds are not appropriated, any resulting contract will become invalid, without penalty to the State of Colorado.

VI. Specifications

Sterile syringes must be available with the following features:

A. 31 gauge cc 1 size 5/16 B. 31 gauge cc ½ size 5/16 C. 31 gauge cc ½ size 15/64 D. 31 gauge cc 3/10 size 5/16 E. 30 gauge cc 1 size ½ F. 30 gauge cc 1 size 5/16 G. 30 gauge cc ½ size 5/16 H. 30 gauge cc 3/10 size 5/16 I. 29 gauge cc 1 size ½ J. 29 gauge cc ½ size ½ K. 28 gauge cc 1 size ½ L. 27 gauge cc 1 size ½ M. 27 gauge cc 1 size 5/8 N. 25 gauge cc ½ size ½ O. Acceptable brands are limited to BD, Easy Touch, Sure Comfort

VII. The successful bidder shall provide the following items:

A. Describe the mode of shipping for syringe orders and any lead time to process and ship orders.

B. CDPHE will place the syringe orders directly with the contractor. CDPHE will reference the local SAP when placing an order. The contractor shall ship the product directly to the SAP address.

C. The syringe orders shall be shipped directly to individual SAP locations by the contractor.

VIII. Delivery CDPHE will verify that each agency is operating a legal SAP that has been authorized by their county or district board of health. CDPHE will provide shipping addresses with contact names and email addresses for each delivery location to the vendor for each order.

IX. Response A. See Administrative Information Form for additional response requirements.

B. Vendor shall submit a completed and signed IFB Pricing Sheet.

C. Vendor shall quote a per-location cost on the IFB Pricing Sheet. Cost per box of 100 shall include all shipping and handling charges.

D. Vendor shall submit documentation showing that the proposed syringe units meet requirements listed in this IFB.

E. Clearly describe any restrictions in shipping syringes to a third party.

X. The bid pricing sheet includes pricing tables for three (3) years. Identify shipping and handling charges for the SAP Physical Addresses. Pricing for the syringes shall be firm prices through June 30, 2017. Any requests to increase pricing above what is listed on the bid pricing sheet in the subsequent two (2) years must be submitted for approval in writing, with justification, to the

4 of 4|

Colorado Integrated Care and Prevention program sixty (60) days prior to the requested effective date of the price increase. Requested price increases shall be comparable to similar product increases across the industry. CDPHE reserves the right to reject any price increase requests solely at its discretion. CDPHE reserves the right to terminate the contract and issue a new solicitation if it deems the price increases to be excessive.

XI. Award Award of this solicitation will be made to the lowest-cost eligible bidder who is both ‘responsive’ (meeting the terms and specifications of the solicitation) and ‘responsible’ (deemed by CDPHE to be capable of meeting the bid requirements).

Any information requested in this solicitation that is not furnished by the bidder may result in the bid being deemed ‘non-responsive’ and ineligible for award.

XII. Exhibits/Attachments

A. Exhibit A: Price Sheet B. Exhibit B: IFB Administrative Information form C. Exhibit C: Vendor Information and Confirmation of Offer Form D. Exhibit D: State of Colorado Purchase Order Terms and Conditions